法人情報

お気に入りページ登録に失敗しました
お気に入りページ解除に失敗しました
すでにお気に入り登録済みのページです
自社はお気に入り登録できません

最終更新日時: 2021/07/30 15:43:55

Osteo Pharma Co.,Ltd.

Development of bone formation drugs by using bone morphogenetic proteins (BMP)

We successfully reduced manufacturing costs by using BMP derived from the Escherichia coli expression system.
The use of BMP withβ-TCP allows us to provide healthcare providers with highly osteogenic bone grating materials having both osteoinductive and osteoconductive properties.

お問い合わせ
メイン画像

アピールポイント

Artificial bones containing BMP
Drug for treatment of pseudoarthritis
Broken bones usually heal by themselves over time. When failure of bony union takes place due to underlying health conditions or other reasons, pseudoarthrosis is suspected. Under this circumstance, a bone graft taken from the patient's own bone is used to achieve bony union at the pseudoarthrosis site. The use of our artificial bones containing BMP, which is still under development, is a promising treatment for patients with pseudoarthrosis, which can achieve not only bony union but also save patients the trouble of having to undergo harvesting of autologous bone.
Increasing the amount of bone for placement of a dental implant
Sufficient alveolar bone volume is required for adequate placement of a dental implant. The lack of sufficient alveolar bone volume can prevent some patients from receiving implant therapy, or can lead to poor prognosis when implant therapy is carried out regardless. The use of our artificial bones containing BMP, which is still under development, is a promising treatment that can save patients the trouble of having to undergo harvesting of autologous bone (which is highly invasive).

カタログ・パンフレット・提案資料

会社プロジェクト概要.pdf

この企業は以下の支援機関から推薦されています

国立研究開発法人新エネルギー・産業技術総合開発機構(NEDO)
お問い合わせ